Watson To Commercialize New Emergency Contraceptive In US
UPA is a new emergency contraceptive developed by HRA Pharma specifically for emergency contraceptive use, that is approved and marketed by HRA Pharma in Europe as ellaOne since
The US Food and Drug Administration (FDA) has expanded the approved indication for Bristol Myers Squibb’s (BMS) Camzyos (mavacamten) to treat symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adults and paediatric patients weighing at least 30kg (66lb).
Lexan Universal Precaution Stations are typically installed in all patient care areas, outside patient rooms, hospital hallways and intensive care areas. The stations neatly organize and make available